Vanguard Portfolio Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.3B Buy
20,999,744
+140,527
+0.7% +$166M 1.1% 10
2026
Q2
$25B Sell
20,859,217
-117,810
-0.6% -$120M 1.13% 9
2026
Q1
$19.3B Buy
+20,977,027
New +$21.3B 1.01% 10

Other funds holding LLY

Vanguard Portfolio Management's LLY Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Eli Lilly (LLY) stake by 0.67% in Q3 2026, buying an estimated $166M and bringing the position to 20,999,744 shares worth $24.3B. The position accounts for 1.1% of the portfolio, ranked #10.

Vanguard Portfolio Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $25B in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vanguard Portfolio Management held 20,999,744 shares of Eli Lilly worth $24.3B as of Q3 2026.
  • Vanguard Portfolio Management bought 140,527 Eli Lilly shares in Q3 2026, an estimated $166M.
  • Eli Lilly made up 1.1% of Vanguard Portfolio Management's portfolio in Q3 2026, its #10 holding.
  • Vanguard Portfolio Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Eli Lilly position peaked at $25B in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.